Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,428Revenue $M7.0Net Margin (%)-866.8Z-Score23.6
Enterprise Value $M1,310EPS $-0.6Operating Margin %-871.0F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-866.8Higher ROA y-yY
Price/Book14.510-y EBITDA Growth Rate %0Quick Ratio4.3Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio4.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-78.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-94.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M91.8ROI % (ttm)-34.8Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 15.531%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 15.5310%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 15.534%New holding, 6310850 sh.6,310,850
KERXJohn Burbank 2012-12-31 Sold Out -0.06%$2.31 - $3.14
($2.72)
$ 15.53471%Sold Out0
KERXJohn Burbank 2012-09-30 Buy 0.06%$1.79 - $2.83
($2.08)
$ 15.53647%New holding, 500000 sh.500,000
KERXGeorge Soros 2006-09-30 Sold Out -0.04%$9.8 - $13.84
($12.1)
$ 15.5328%Sold Out0
KERXGeorge Soros 2006-06-30 Buy 0.04%$12.64 - $17.44
($15.3)
$ 15.532%New holding, 30000 sh.30,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
KERX Seth Klarman 2014-09-3018,300,00019.934.4+73.62%
Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENTSUR RONCEO 2014-10-06Sell70,838$15.88-4.66view
Oliviero James F IIICFO 2014-10-03Sell2,694$16.14-6.2view
BENTSUR RONCEO 2014-09-12Sell50,000$14.246.32view
Oliviero James F IIICFO 2014-09-08Sell144,237$15.88-4.66view
Oliviero James F IIICFO 2014-07-07Sell2,054$15.75-3.87view
BENTSUR RONCEO 2014-07-07Sell1,788$15.75-3.87view
BENTSUR RONCEO 2014-04-03Sell1,816$16.46-8.02view
Oliviero James F IIICFO 2014-04-03Sell2,087$16.46-8.02view
Oliviero James F IIICFO 2014-03-21Sell292,483$15.140view
BENTSUR RONCEO 2014-01-03Sell5,257$12.5720.45view

Press Releases about KERX :

    Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    Baupost’s Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd Gaming, Nov 14 2014 
    Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sel Aug 14 2014 
    Seth Klarman Tops Guru Scoreboard for First Half 2014 Jul 05 2014 
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD Mar 24 2014 
    Weekly Insider Sells Highlight: FLT, KERX, KOG, MEI, HTZ Jan 06 2014 
    comment on KERX Mar 02 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Bio drug Nov 03 2011 

    More From Other Websites
    Mid-Day Market Update: SunEdison, TerraForm Jump On First Wind Acquisition; TJX Shares Drop Nov 18 2014
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 18 2014
    Keryx Biopharmaceuticals Announces Trade Name Auryxia(TM) for Ferric Citrate Nov 17 2014
    Keryx Biopharmaceuticals Announces Trade Name Auryxia(TM) for Ferric Citrate Nov 17 2014
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Nov 17 2014
    1:17 am Keryx Biopharma announces results from Ferric Citrate Phase 3 long-term safety extension... Nov 17 2014
    Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension... Nov 15 2014
    Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension... Nov 15 2014
    Baupost's Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd ... Nov 14 2014
    KERYX BIOPHARMACEUTICALS INC Financials Nov 14 2014
    Keryx Biopharmaceuticals, Inc. to Present at the Stifel 2014 Healthcare Conference Nov 14 2014
    Keryx Biopharmaceuticals, Inc. to Present at the Stifel 2014 Healthcare Conference Nov 14 2014
    A quarterback's market playbook Nov 12 2014
    Lighting Round: This one is a strong buy Nov 10 2014
    10-Q for Keryx Biopharmaceuticals, Inc. Nov 08 2014
    Keryx Biopharmaceuticals (KERX) Highlighted As Today's Perilous Reversal Stock Nov 07 2014
    Keryx (KERX) in Focus: Stock Adds 11.9% in Session Nov 07 2014
    Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today Nov 06 2014
    Keryx Biopharmaceuticals, Inc. Announces Third Quarter and Nine Month 2014 Financial Results Nov 06 2014
    Keryx Biopharma misses Street 3Q forecasts Nov 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK